Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Thomas H. Schindler(University Hospital of Geneva), John Kuriyan(Vanderbilt University), Patricia Pellicena(State University of New York), W. Todd Miller(Memorial Sloan Kettering Cancer Center), William G. Bornmann(Memorial Sloan Kettering Cancer Center), Bayard Clarkson(Memorial Sloan Kettering Cancer Center)
Cited by 1,774
Related Papers
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
|Cell|2006|1.6k
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
|Cancer Cell|2002|1.6k
Crystal structure of the Src family tyrosine kinase Hck
|Nature|1997|1.2k